3D Global Biotech Inc. (TPEX: 6808)
Taiwan
· Delayed Price · Currency is TWD
36.15
+0.05 (0.14%)
Nov 15, 2024, 2:59 PM CST
3D Global Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Net Income | -29.41 | -57.95 | -67.09 | -59.71 | -47.92 | -36.32 | Upgrade
|
Depreciation & Amortization | 22.5 | 22.74 | 25.58 | 24.59 | 24.05 | 15.28 | Upgrade
|
Other Amortization | 0.03 | 0.15 | 0.29 | 0.29 | 0.29 | 0.28 | Upgrade
|
Loss (Gain) From Sale of Assets | -0 | - | - | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 18.89 | - | - | - | Upgrade
|
Stock-Based Compensation | 0.33 | 0.12 | 0.28 | 0.6 | 0.52 | 0.65 | Upgrade
|
Other Operating Activities | -1.29 | -0.98 | -16.08 | -1 | -0.23 | 2.65 | Upgrade
|
Change in Accounts Receivable | 1.71 | -0.25 | 0.14 | 0.42 | 0.37 | -0.84 | Upgrade
|
Change in Inventory | -39.47 | -0.23 | -2.49 | 0.26 | 0.04 | -0.53 | Upgrade
|
Change in Accounts Payable | 37.95 | 1.11 | 1.56 | -0.26 | -0.22 | 0.14 | Upgrade
|
Change in Unearned Revenue | -2.22 | 5.09 | 1.51 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | -1.18 | -1.42 | 2.93 | -1.18 | -0.12 | 1.05 | Upgrade
|
Operating Cash Flow | -11.05 | -31.61 | -34.49 | -35.99 | -23.23 | -17.64 | Upgrade
|
Capital Expenditures | -2.61 | -0.78 | -0.85 | -2.86 | -0.03 | -0.04 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -0.01 | -0.02 | - | -0.16 | Upgrade
|
Investment in Securities | -103.9 | 33.7 | 19.9 | 55.5 | 19.8 | -120.1 | Upgrade
|
Other Investing Activities | 0.81 | 0.66 | -0.85 | -0.33 | - | - | Upgrade
|
Investing Cash Flow | -105.66 | 33.58 | 18.2 | 52.29 | 19.77 | -120.3 | Upgrade
|
Long-Term Debt Repaid | - | -6.37 | -6.25 | -4.47 | -4.03 | -3.98 | Upgrade
|
Net Debt Issued (Repaid) | -6.46 | -6.37 | -6.25 | -4.47 | -4.03 | -3.98 | Upgrade
|
Issuance of Common Stock | 173.59 | 10.69 | 17.7 | - | 7.2 | 130 | Upgrade
|
Other Financing Activities | -0.11 | - | - | 0.11 | - | - | Upgrade
|
Financing Cash Flow | 167.03 | 4.32 | 11.45 | -4.36 | 3.18 | 126.02 | Upgrade
|
Net Cash Flow | 50.32 | 6.29 | -4.84 | 11.94 | -0.28 | -11.91 | Upgrade
|
Free Cash Flow | -13.66 | -32.39 | -35.33 | -38.85 | -23.26 | -17.67 | Upgrade
|
Free Cash Flow Margin | -24.76% | -156.99% | -258.98% | -350.81% | -175.38% | -97.23% | Upgrade
|
Free Cash Flow Per Share | -0.23 | -0.58 | -0.64 | -0.72 | -0.43 | -0.35 | Upgrade
|
Cash Interest Paid | 0.13 | 0.18 | 0.26 | 0.26 | 0.1 | 0.05 | Upgrade
|
Cash Income Tax Paid | 0.03 | -0.02 | -0.06 | -0.05 | -0.05 | -0.05 | Upgrade
|
Levered Free Cash Flow | -4.91 | -12.83 | -12.85 | -16.98 | -4.99 | -6.92 | Upgrade
|
Unlevered Free Cash Flow | -4.83 | -12.72 | -12.7 | -16.82 | -4.93 | -6.89 | Upgrade
|
Change in Net Working Capital | 3.18 | -4.33 | -3.45 | 0.53 | -1.7 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.